Characterization of stress degradation products of bedaquiline fumarate and bedaquiline by LC-PDA and LC-MS

Guo, Kaijing; Wang, Yanan; Ma, Chen

doi:10.1016/j.jpba.2023.115658

Journal of Pharmaceutical and Biomedical Analysis

2023

DOI: 10.1016/j.jpba.2023.115658

|View full text |Cite

Characterization of stress degradation products of bedaquiline fumarate and bedaquiline by LC-PDA and LC-MS

Kaijing Guo,

Yanan Wang,

Chen Ma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Separation, Identification, and Characterization of Transformation Products Related to Relugolix Upon Subjecting to In Vitro Gastrointestinal Fluids Utilizing Liquid Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy

Golla,

Chary,

Naik

et al. 2024

Separation Science Plus

View full text Add to dashboard Cite

This study investigated the gastrointestinal stability of relugolix, a biopharmaceutical classification system Class IV drug. Relugolix was found to be unstable in simulated gastric fluid but stable in simulated intestinal fluid and fed‐state–simulated gastric fluid. The high‐performance liquid chromatography method was developed and validated for separating the drug and its transformation products. The optimized method comprises mobile phase ammonium acetate (pH 4.75) as Solvent A and acetonitrile as Solvent B. A Phenomenex Gemini C18 (250 × 4.6 mm, 5 µm) column was used as the stationary phase. The transformation product, desmethyl relugolix, was identified and characterized using high‐resolution mass spectrometric and nuclear magnetic spectroscopic studies by enriching the compound using forced degradation studies under acidic stress hydrolytic conditions. Sodium alginate microspheres were prepared and evaluated to improve relugolix stability in the stomach. Additionally, gastrointestinal stability studies demonstrated that the microspheres protected relugolix from degradation in simulated gastric fluid. In silico analysis predicted minimal toxicity risks for both relugolix and desmethyl relugolix. These findings suggest that relugolix sodium alginate microspheres could be a promising strategy to mitigate the formation of desmethyl relugolix by protecting it from degradation in the stomach's acidic environment.

show abstract

Separation, Identification, and Characterization of Transformation Products Related to Relugolix Upon Subjecting to In Vitro Gastrointestinal Fluids Utilizing Liquid Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy

Golla,

Chary,

Naik

et al. 2024

Separation Science Plus

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Characterization of stress degradation products of bedaquiline fumarate and bedaquiline by LC-PDA and LC-MS

Cited by 1 publication

References 15 publications

Separation, Identification, and Characterization of Transformation Products Related to Relugolix Upon Subjecting to In Vitro Gastrointestinal Fluids Utilizing Liquid Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy

Separation, Identification, and Characterization of Transformation Products Related to Relugolix Upon Subjecting to In Vitro Gastrointestinal Fluids Utilizing Liquid Chromatography, Mass Spectrometry, and Nuclear Magnetic Resonance Spectroscopy

Contact Info

Product

Resources

About